medigraphic.com
Instituto Nacional de Salud Pública

2002, Número 2

<< Anterior Siguiente >>

salud publica mex 2002; 44 (2)


The centennial of the Yellow Fever Commission and the use of informed consent in medical research

Güereña-Burgueño F

Idioma: Español
Referencias bibliográficas: 28
Paginas: 140-144
Archivo PDF: 354.00 Kb.


RESUMEN

En el año 2000 se cumplió el primer centenario del descubrimiento del modo de transmisión de la fiebre amarilla. El consentimiento informado fue utilizado por primera vez de manera sistemática en una investigación médica. Este proceso fue el resultado de un fenómeno social complejo que involucró a la Asociación Americana de Salud Pública, a los gobiernos de los Estados Unidos de América y España, a científicos norteamericanos y cubanos, a la prensa y a voluntarios civiles y militares. Al inicio del siglo XXI las comunidades de salud pública y médicas en el ámbito internacional enfrentan la pandemia de SIDA al igual que enfrentaron a la fiebre amarilla al iniciarse el siglo XX. A la vez, también debaten los retos éticos que la investigación médica contemporánea les ofrece, especialmente en los países en desarrollo. La reflexión sobre los experimentos de 1900 podría ofrecer enseñanzas aplicables a los retos éticos enfrentados por las comunidades internacionales de investigación en salud pública.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Keperlman LC, Connel DB, Gunn WJ. Effect of a monetary sanction on immunization rates of recipients of aid to families with dependent children. JAMA 2000;284:53-59.

  2. Davis MM, Lantos JD. Ethical considerations in the public policy laboratory. JAMA 2000;284:85-87.

  3. Marshall E. Gene therapy on trial. Science 2000;288:951-957.

  4. Malakoff M. Flawed cancer study leads to shake-up at University of Oklahoma. Science 2000;289:706-707.

  5. Marshall E. HHS plans to overhaul clinical research rules. Science 2000;288:1315-1316.

  6. Marshall E. Harvard’s Koski to lead human subjects office. Science 2000;288:1349.

  7. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire- Mangen F et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000;342:921-929.

  8. Angell M. Investigator’s responsibilities for human subjects in developing countries. N Engl J Med 2000; 342:967-969.

  9. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. N Engl J Med 1998;338: 1003-1005.

  10. Levine RJ. The need to revise the declaration of Helsinki. N Engl J Med 1999;341:531-534.

  11. Brennan TA. Proposed revisions to the Declaration of Helsinki –Will they weaken the ethical principles underlying human research? N Engl J Med 1999;341:527-531.

  12. Reed W, Carrol J. The prevention of yellow fever. Public Health Papers and Reports. Presented at the Twenty-Ninth Annual Meeting of the American Public Health Association; September 16-18, 19 and 1901;20. Buffalo (NY). Columbus (OH): The Berlin Printing Company, 1902;Vol. XXVII:113-129.

  13. Holbreck HB. Report of the Committee of Etiology of Yellow Fever. Public Health Papers and Reports. Presented at the Twenty-Sixth Annual Meeting of the American Public Health Association. September 1898;27- 30. Ottawa, Canada. Columbus (OH): The Berlin Printing Company, 1898; Vol. XXIV:116-127.

  14. Gorgas WC. Sanitation in the Canal Zone. JAMA 1907;Jul 6:6-8.

  15. Holbreck HB. Report of the Committee of Etiology of Yellow Fever. Public Health Papers and Reports. Presented at the Twenty-Seventh Annual Meeting of the American Public Health Association; October 31, and November 1899;1-3. Minneapolis, MN. Columbus (OH): The Berlin Printing Company, 1900;Vol. XXV:24-32.

  16. Reed W, Carroll J, Agramonte A, Lazear JW. The etiology of yellow fever. –A preliminary note. Public Health Papers and Reports. Presented at the Twenty-Eight Annual Meeting of the American Public Health Association, October 1900;22-26. Indianapolis, IN. Columbus (OH): The Berlin Printing Company, 1901;Vol. XXVI:37-53.

  17. Reed W, Carroll J, Agramonte A. The etiology of yellow fever and additional notes. JAMA 1901;Feb 16:431-439.

  18. Finlay CJ. President’s address. Public Health Papers and Reports, Vol. XXX. Presented at the Thirty-Second Annual Meeting of the American Public Health Association, January 1905;9-13. Havana Cuba. Columbus(OH): The Berlin Printing Company, 1905:1-7.

  19. Lee B. A tribute to Carlos J. Finlay for his distinguished services to science and humanity in the discovery of the propagation of yellow fever. Public Health Papers and Reports. Presented at the Thirty-Second Annual Meeting of the American Public Health Association, Havana, Cuba January 9, 10, 11, 12, 13. 1905. Columbus (OH): The Berlin Printing Company 1905;Vol. XXX:8-14.

  20. Gorgas WC. The results of yellow fever sanitation in Havana, Cuba, for the Year 1901 up to September 1st, carried on upon the basis that the Stegomya mosquito is the sole means of its transmission. Public Health Reports. Presented at the Twenty-Ninth Annual Meeting of the American Public Health Association; 1901;September 16-20. Buffalo NY. Columbus (OH): The Berlin Printing Company, 1902;Vol. XXVII:130-133.

  21. Bean WB. The Fielding H. Harrison Lecture: Walter Reed and the ordeal of human experiments. Bull History Med 1977;51:75-92.

  22. Agramonte A. The inside history of a great medical discovery. Scientific Monthly 1915;1:209-237.

  23. Pan-American Medical Congress held in Havana, Cuba, February 4. Etiology of yellow fever. JAMA 1901;Feb 16:461-462.

  24. The Nuremberg Code. JAMA 1996;276:1691.

  25. The brutalities of nazi physicians. JAMA 1946;Nov 23:714-715.

  26. World Medical Association Declaration of Helsinki. JAMA 1997;277: 925-926.

  27. Ajlouni KM. History of informed medical consent. Lancet 1995;346:980.

  28. Ruthkov IM. Beaumont and St Martin: A blast from the past. Arch Surg 1998;133:1259.




2020     |     www.medigraphic.com